Recommendations

ACC - www.acc.org
AHA - www.americanheart.org
SCAI - www.scai.org
Smith et al. 2005
ACC/AHA/SCAI Practice Guidelines
109
Cardiol 2003;15:380-4.
507. Chan AW, Chew DP, Bhatt DL, Moliterno DJ, Topol EJ, Ellis SG.
Long-term mortality benefit with the combination of stents and
abciximab for cardiogenic shock complicating acute myocardial
infarction. Am J Cardiol 2002;89:132-6.
508. Giri S, Mitchel J, Azar RR, et al. Results of primary percutaneous
transluminal coronary angioplasty plus abciximab with or without
stenting for acute myocardial infarction complicated by cardiogenic
shock. Am J Cardiol 2002;89:126-31.
509. Antoniucci D, Valenti R, Migliorini A, et al. Abciximab therapy
improves survival in patients with acute myocardial infarction
complicated by early cardiogenic shock undergoing coronary
artery stent implantation. Am J Cardiol 2002;90:353-7.
510. Hochman JS. Cardiogenic shock complicating acute myocardial
infarction: expanding the paradigm. Circulation 2003;107:2998-
3002.
511. Nicod P, Gilpin EA, Dittrich H, et al. Trends in use of coronary
angiography in subacute phase of myocardial infarction.
Circulation 1991;84:1004-15.
512. Mehta RH, Harjai KJ, Cox D, et al. Clinical and angiographic correlates
and outcomes of suboptimal coronary flow inpatients with
acute myocardial infarction undergoing primary percutaneous
coronary intervention. J Am Coll Cardiol 2003;42:1739-46.
513. Berger AK, Radford MJ, Wang Y, Krumholz HM. Thrombolytic
therapy in older patients. J Am Coll Cardiol 2000;36:366-74.
514. Holmes DR, Jr., White HD, Pieper KS, Ellis SG, Califf RM, Topol
EJ. Effect of age on outcome with primary angioplasty versus
thrombolysis. J Am Coll Cardiol 1999;33:412-9.
515. Aguirre FV, McMahon RP, Mueller H, et al. Impact of age on
clinical outcome and postlytic management strategies in patients
treated with intravenous thrombolytic therapy: results from the
TIMI II Study. TIMI II Investigators. Circulation 1994;90:78-86.
516. Schulman SP, Achuff SC, Griffith LS, et al. Prognostic cardiac
catheterization variables in survivors of acute myocardial infarction:
a five year prospective study. J Am Coll Cardiol 1988;11:
1164-72.
517. An international randomized trial comparing four thrombolytic
strategies for acute myocardial infarction. The GUSTO investigators.
N Engl J Med 1993;329:673-82.
518. Lincoff AM, Califf RM, Van de WF, et al. Mortality at 1 year with
combination platelet glycoprotein IIb/IIIa inhibition and reduceddose
fibrinolytic therapy vs conventional fibrinolytic therapy for
acute myocardial infarction: GUSTO V randomized trial. JAMA
2002;288:2130-5.
519. Hudson MP, Granger CB, Topol EJ, et al. Early reinfarction after
fibrinolysis: experience from the global utilization of streptokinase
and tissue plasminogen activator (alteplase) for occluded
coronary arteries (GUSTO I) and global use of strategies to open
occluded coronary arteries (GUSTO III) trials. Circulation
2001;104:1229-35.
520. Mueller HS, Cohen LS, Braunwald E, et al. Predictors of early
morbidity and mortality after thrombolytic therapy of acute
myocardial infarction: analyses of patient subgroups in the
Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.
Circulation 1992;85:1254-64.
521. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital
mortality in the global registry of acute coronary events. Arch
Intern Med 2003;163:2345-53.
522. Campeau L, Lesperance J, Bourassa MG. Natural history of
saphenous vein aortacoronary bypass grafts. Mod Concepts
Cardiovasc Dis 1984;54:59-63.
523. Bourassa MG. Fate of venous grafts: the past, the present and the
future. J Am Coll Cardiol 1991;17:1081-3.
524. FitzGibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD,
Burton JR. Coronary bypass graft fate and patient outcome:
angiographic follow-up of 5,065 grafts related to survival and
reoperation in 1,388 patients during 25 years. J Am Coll Cardiol
1996;28:616-26.
525. Cox JL, Chiasson DA, Gotlieb AI. Stranger in a strange land: the
pathogenesis of saphenous vein graft stenosis with emphasis on
structural and functional differences between veins and arteries.
Prog Cardiovasc Dis 1991;34:45-68.
526. Kahn JK, Rutherford BD, McConahay DR, et al. Early postoperative
balloon coronary angioplasty for failed coronary artery
bypass grafting. Am J Cardiol 1990;66:943-6.
527. Dimas AP, Arora RR, Whitlow PL, et al. Percutaneous transluminal
angioplasty involving internal mammary artery grafts. Am
Heart J 1991;122:423-9.
528. Dorogy ME, Highfill WT, Davis RC. Use of angioplasty in the
management of complicated perioperative infarction following
bypass surgery. Cathet Cardiovasc Diagn 1993;29:279-82.
529. Rentrop P, Blanke H, Karsch KR, Kostering H, Oster H, Leitz H.
Recanalization of an acutely occluded aortocoronary bypass by
intragraft fibrinolysis. Circulation 1980;62:1123-6.
530. Holmes DRJ, Chesebro JH, Vlietstra RE, Orszulak TA.
Streptokinase for vein graft thrombosis--a caveat. Circulation
1981;63:729.
531. Marx M, Armstrong WP, Wack JP, et al. Short-duration, high-dose
urokinase infusion for recanalization of occluded saphenous aortocoronary
bypass grafts. AJR Am J Roentgenol 1989;153:167-71.
532. Hartzler GO, Johnson WL, McConahay DR, et al. Dissolution of
coronary artery bypass graft thrombi by streptokinase infusion.
Am J Cardiol 1981;47:493.
533. van Ommen VG, van den Bos AA, Pieper M, et al. Removal of
thrombus from aortocoronary bypass grafts and coronary arteries
using the 6Fr Hydrolyser. Am J Cardiol 1997;79:1012-6.
534. Douglas JSJ, Gruentzig AR, King SB3, et al. Percutaneous transluminal
coronary angioplasty in patients with prior coronary
bypass surgery. J Am Coll Cardiol 1983;2:745-54.
535. Reeves F, Bonan R, Cote G, et al. Long-term angiographic followup
after angioplasty of venous coronary bypass grafts. Am Heart
J 1991;122:620-7.
536. Meester BJ, Samson M, Suryapranata H, et al. Long-term followup
after attempted angioplasty of saphenous vein grafts: the
Thoraxcenter experience 1981-1988. Eur Heart J 1991;12:648-53.
537. de Feyter PJ, van Suylen RJ, de Jaegere PP, Topol EJ, Serruys
PW. Balloon angioplasty for the treatment of lesions in saphenous
vein bypass grafts. J Am Coll Cardiol 1993;21:1539-49.
538. Gruberg L, Hong MK, Mehran R, et al. In-hospital and long-term
results of stent deployment compared with balloon angioplasty for
treatment of narrowing at the saphenous vein graft distal anastomosis
site. Am J Cardiol 1999;84:1381-4.
539. Strauss BH, Natarajan MK, Batchelor WB, et al. Early and late
quantitative angiographic results of vein graft lesions treated by
excimer laser with adjunctive balloon angioplasty. Circulation
1995;92:348-56.
540. Bittl JA, Sanborn TA, Yardley DE, et al. Predictors of outcome of
percutaneous excimer laser coronary angioplasty of saphenous
vein bypass graft lesions: the Percutaneous Excimer Laser
Coronary Angioplasty Registry. Am J Cardiol 1994;74:144-8.
541. Stullman WS, Hilliard GK. Unrecognized internal mammary
artery stenosis treated by percutaneous angioplasty after coronary
bypass surgery. Am Heart J 1987;113:393-5.
542. Vivekaphirat V, Yellen SF, Foschi A. Percutaneous transluminal